Lung cancer Treatment in Lokman Hekim Akay Hospital

Lung cancer treatment at Lokman Hekim Akay Hospital in Ankara, Turkey, is based on personalized genetic analysis. Diagnostic consultations are included, and advanced Keytruda immunotherapy may cost around $3,000. The clinic stands out for its approach, tailoring therapy plans to the specific genetic profile of a patient's tumor.

The treatment process begins with a comprehensive diagnostic package. This typically includes a consultation with an oncologist and all necessary further examinations.

Personalized Treatment Options

Therapy is guided by tumor gene mapping, also known as molecular profiling. This test identifies specific mutations in the cancer. It allows doctors to choose the most effective targeted treatment. Lokman Hekim Akay Hospital offers two main immunotherapy options:

• Keytruda (Pembrolizumab) immunotherapy: This is a smart, targeted therapy for lung cancer. A treatment package including the drug, doctor consultation, and examinations may cost around $3,000.
• Durvalumab + Tremelimumab therapy: This dual immunotherapy combination is often recommended as an alternative. It provides another advanced option for patients.

The clinic has earned a 4.5 out of 5 patient rating. It also maintains a 91% client recommendation rate. Services for international patients are included, like airport transfers and an interpreter. To explore a personalized treatment plan based on your specific diagnosis, contact the clinic for more information.